Los Angeles Biotech Trending News

Fresh off FerGene’s meltdown, David Meek takes over at Mirati with lead KRAS drug racing to an approval

In the insular world of biotech, a spectacular failure can sometimes stay on any executive’s record for a long time. But for David Meek, the man at the helm of FerGene’s recent implosion, two questionable […]

No Picture
News

Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test

SAN DIEGO, Sept. 19, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19, today […]

No Picture
Los Angeles Biotech Trending News

Mirati’s KRAS drug looks like the favorite in colon cancer with new data, putting the pressure square on Amgen

With Amgen already providing proof-of-concept for KRAS inhibitors with its sotorasib, Mirati Therapeutics is piecing together a follow-up effort in lung cancer with data it thinks are superior. But in colon cancer, where solo sotorasib […]

News

Epic Sciences Comprehensive Cancer Profiling Platform Shows Compelling Value Of Cell Analysis In Data Presented At ESMO Congress 2021

SAN DIEGO: SAN DIEGO, Sept. 18, 2021 /PRNewswire/ — Epic Sciences, Inc.’s (Epic) Comprehensive Cancer Profiling Platform continues to deliver compelling cell analysis information in clinical trials as data being presented today at the virtual […]

No Picture
News

Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE “Off-the-Shelf” Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical Trial

EMERYVILLE, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) —  Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced results with its SLATE v1 product (“off-the-shelf” shared […]

No Picture
Boston Cambridge Biotech Trending News

EyePoint Pharmaceuticals to Present Data at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting

WATERTOWN, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that […]

News

BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform.

SAN DIEGO: SAN DIEGO, Sept. 17, 2021 /PRNewswire/ — BioFluidica, a privately held biotechnology company, announced its plans to commercialize the market’s first and only high throughput rare biomarker (circulating tumor cells, exosomes, and cell-free […]